LENSAR, Inc. (LNSR) vs Microbot Medical Inc. (MBOT)

LENSAR, Inc. and Microbot Medical Inc. are both Medical Devices companies. LENSAR, Inc. and Microbot Medical Inc. are of similar size ($71.9M and $67.6M). Microbot Medical Inc. has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 3.9×. LENSAR, Inc. grew revenue faster over the last twelve months: 3.26% against −59.1%. LENSAR, Inc. has the higher net margin (57.6% vs −3,955.2%) and the higher return on invested capital (−379.0% vs −850.5%). Across the 17 metrics below, LENSAR, Inc. leads on 13 and Microbot Medical Inc. on 4.

Valuation

Metric LNSR MBOT Medical Devices median
P/E 3.89 n/m 25.58
P/S 1.13 172.34 2.54
P/B 4.55 1.03 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 1.01 15.01 2.72
Earnings yield 25.68% (22.64%) (12.82%)
Free cash flow yield (10.91%) (25.18%) (8.18%)

Profitability

Metric LNSR MBOT Medical Devices median
Gross margin 48.34% (166.30%) 57.76%
Operating margin (13.48%) (4,480.03%) (15.07%)
Net margin 57.57% (3,955.22%) (14.45%)
Free cash flow margin (12.29%) (4,340.11%) (3.88%)
Return on equity (851.75%) (32.91%) (10.35%)
Return on assets 49.58% (30.68%) (17.26%)
Return on invested capital (379.01%) (850.51%) (5.27%)

Growth

Metric LNSR MBOT Medical Devices median
Revenue growth (TTM) 3.26% (59.09%) 10.41%
EPS growth (last fiscal year) (5.13%) 60.27% 28.17%
Revenue growth, 5-year CAGR 17.24% 0.39% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNSR MBOT Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 2.39 18.56 2.74
Net debt to EBITDA 0.89 5.35 0.54

Dividend

Metric LNSR MBOT Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric LNSR MBOT Medical Devices median
Market cap 67.57m 71.87m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack